SE7810002L - Forfarande for framstellning av fenylalkylaminer - Google Patents

Forfarande for framstellning av fenylalkylaminer

Info

Publication number
SE7810002L
SE7810002L SE7810002A SE7810002A SE7810002L SE 7810002 L SE7810002 L SE 7810002L SE 7810002 A SE7810002 A SE 7810002A SE 7810002 A SE7810002 A SE 7810002A SE 7810002 L SE7810002 L SE 7810002L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
phenyl alkylamines
alkylamines
phenyl
Prior art date
Application number
SE7810002A
Other languages
English (en)
Inventor
K Schromm
A Mentrup
E O Renth
L Pichler
W Traunecker
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE7810002L publication Critical patent/SE7810002L/sv
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7810002A 1974-04-27 1978-09-26 Forfarande for framstellning av fenylalkylaminer SE7810002L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420618A DE2420618C2 (de) 1974-04-27 1974-04-27 Aminoalkylanilide, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen, die diese Aminoalkylanilide enthalten

Publications (1)

Publication Number Publication Date
SE7810002L true SE7810002L (sv) 1978-09-22

Family

ID=5914207

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7504858A SE411205B (sv) 1974-04-27 1975-04-25 Analogiforfarande for framstellning av fenylalkylaminer
SE7810002A SE7810002L (sv) 1974-04-27 1978-09-26 Forfarande for framstellning av fenylalkylaminer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7504858A SE411205B (sv) 1974-04-27 1975-04-25 Analogiforfarande for framstellning av fenylalkylaminer

Country Status (27)

Country Link
US (1) US4015011A (sv)
JP (1) JPS5828269B2 (sv)
AT (1) AT350529B (sv)
BE (1) BE828430A (sv)
BG (2) BG26372A4 (sv)
CA (1) CA1061357A (sv)
CH (3) CH614697A5 (sv)
CS (2) CS216828B2 (sv)
DD (1) DD122374A5 (sv)
DE (1) DE2420618C2 (sv)
DK (1) DK180675A (sv)
ES (7) ES437032A1 (sv)
FI (1) FI63931C (sv)
FR (1) FR2268520B1 (sv)
GB (1) GB1501436A (sv)
HU (1) HU172615B (sv)
IE (1) IE42119B1 (sv)
IL (1) IL47170A (sv)
NL (1) NL7504917A (sv)
NO (1) NO141207C (sv)
PH (2) PH11982A (sv)
PL (2) PL96308B1 (sv)
RO (2) RO70894A (sv)
SE (2) SE411205B (sv)
SU (2) SU555843A3 (sv)
YU (1) YU105275A (sv)
ZA (1) ZA752685B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163060A (en) * 1974-04-08 1979-07-31 U.S. Philips Corporation Aralkylamino carboxylic acids and derivatives having spasmolytic activity
US4146645A (en) * 1974-04-27 1979-03-27 Boehringer Ingelheim Gmbh Hypertensive phenylalkylamines and salts thereof
US4145363A (en) * 1975-02-05 1979-03-20 Yamanouchi Pharmaceutical Co., Ltd. 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives
US4088785A (en) * 1976-03-25 1978-05-09 William H. Rorer, Inc. Amidinoureas for the treatment of cardinascular disorders
US4754047A (en) * 1979-08-16 1988-06-28 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and/or improving the efficiency of feed utilization thereby
US4477470A (en) * 1983-10-20 1984-10-16 Smithkline Beckman Corporation Method for producing diuresis using m-amino-α-methylphenethylamine
JPS6155683U (sv) * 1984-09-17 1986-04-14
JPS61130876U (sv) * 1984-09-18 1986-08-15
ES8606847A1 (es) * 1984-11-08 1986-05-16 Syntex Inc Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
JPH01116184U (sv) * 1988-01-29 1989-08-04
JPH01116183U (sv) * 1988-01-29 1989-08-04
US5741818A (en) * 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
ATE289295T1 (de) * 1997-04-22 2005-03-15 Euro Celtique Sa Die verwendung von durch carbozyklische und heterozyklische reste substituierte semicarbazonen und thiosemicarbazonen als natriumkanalblocker
ATE359993T1 (de) * 1997-08-05 2007-05-15 Pola Chem Ind Inc Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123536C (sv) * 1963-07-09

Also Published As

Publication number Publication date
CS216827B2 (en) 1982-11-26
DD122374A5 (sv) 1976-10-05
PL96224B1 (pl) 1977-12-31
HU172615B (hu) 1978-11-28
ES452510A1 (es) 1977-11-01
PH11982A (en) 1978-10-04
ES437032A1 (es) 1977-04-16
SU555843A3 (ru) 1977-04-25
DE2420618C2 (de) 1982-09-16
SE7504858L (sv) 1975-10-28
BE828430A (fr) 1975-10-27
GB1501436A (en) 1978-02-15
JPS50149630A (sv) 1975-11-29
ES452514A1 (es) 1977-11-01
ES452515A1 (es) 1977-11-01
ES452512A1 (es) 1977-11-01
SE411205B (sv) 1979-12-10
US4015011A (en) 1977-03-29
CH616146A5 (sv) 1980-03-14
RO70894A (ro) 1982-02-26
NO751491L (sv) 1975-10-28
BG26372A4 (bg) 1979-03-15
PL96308B1 (pl) 1977-12-31
PH14732A (en) 1981-11-19
IL47170A0 (en) 1975-06-25
DE2420618A1 (de) 1975-11-13
FI751199A (sv) 1975-10-28
RO81766A (ro) 1983-06-01
YU105275A (en) 1982-02-28
ZA752685B (en) 1976-12-29
NL7504917A (nl) 1975-10-29
IL47170A (en) 1980-07-31
AT350529B (de) 1979-06-11
BG27738A3 (en) 1979-12-12
FR2268520B1 (sv) 1982-02-12
CS216828B2 (en) 1982-11-26
SU606549A3 (ru) 1978-05-05
CA1061357A (en) 1979-08-28
CH616401A5 (sv) 1980-03-31
NO141207B (no) 1979-10-22
ES452513A1 (es) 1977-11-01
FI63931C (fi) 1983-09-12
FR2268520A1 (sv) 1975-11-21
DK180675A (da) 1975-10-28
FI63931B (fi) 1983-05-31
IE42119B1 (en) 1980-06-04
IE42119L (en) 1975-10-27
ATA247875A (de) 1978-11-15
JPS5828269B2 (ja) 1983-06-15
CH614697A5 (sv) 1979-12-14
NO141207C (no) 1980-01-30
ES452511A1 (es) 1977-11-01
AU8051075A (en) 1976-10-28
RO81766B (ro) 1983-05-30

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
SE7513085L (sv) Forfarande for framstellning av etrar
SE412401B (sv) Forfarande for framstellning av polyvinylpyrroliden-jod
SE7503689L (sv) Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer
SE7810002L (sv) Forfarande for framstellning av fenylalkylaminer
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
NO146199C (no) Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE426830B (sv) Forfarande for framstellning av cefalosporinforeningar
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE7512039L (sv) Forfarande for framstellning av jodforer
SE7505751L (sv) Forfarande for framstellning av cefalosporiner
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
SE424548B (sv) Forfarande for framstellning av alkylsulfonylfenoxipropanolaminer
SE421421B (sv) Analogiforfarande for framstellning av antiarytmiska medel